In mouse models of beta-thalassemia intermedia, Kautz et al. found that erythroferrone ablation could restore normal levels of hepcidin and suggested that erythroferrone could result in reduced hepcidin production in beta-thalassemia [43]. This evidence concerns the gene HAMP and beta thalassemia.